Physician profile
David M Dragon
NPI 1790717601
$2,293.58
in general payments reported to CMS, 2019-2025
16 companies · $770 in 2025
The $770 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $463 · 2020: $164 · 2021: $208 · 2022: $206 · 2023: $237 · 2024: $246 · 2025: $770.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,253.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,253.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $988.64 | 2019-2025 | Rocklatan, Argos, Lensx |
| Biotissue Holdings INC. | $466.54 | 2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $207.03 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $115.50 | 2024-2025 | Xdemvy |
| Aerie Pharmaceuticals, INC. | $90.79 | 2019-2021 | |
| Allergan, INC. | $78.17 | 2021-2022 | |
| Oyster Point Pharma, INC. | $72.40 | 2022-2025 | Tyrvaya, Ryzumvi |
| Rayner Intraocular Lenses Limited | $49.72 | 2023 | Rayone Spheric, Rayone Aspheric, Rayone Emv |
| Novartis Pharmaceuticals Corporation | $44.04 | 2019-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $42.60 | 2023-2024 | Tecnis Iol, Catalys System |
| Rxsight INC | $34.98 | 2023-2024 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd) |
| Dompe US, INC. | $27.35 | 2025 | Oxervate |
| Sight Sciences, INC. | $23.90 | 2025 | Omni Surgical System, Sion Surgical Instrument |
| Abbvie INC. | $23.50 | 2024 | |
| Eyepoint US, INC. | $15.81 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $12.61 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Dragon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.